Drug-resistant BRAF V600E-mutant recurrent pleomorphic xanthoastrocytoma, CNS WHO Grade 3 successfully resolved with incidental discontinuation of combined BRAF and MEK inhibitor therapy
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
